Prodrug |
S1037 |
3-Diazirine-Derivatives of bile acid |
Increasing uptake, inhibited by taurocholate |
[113] |
Prodrug |
acyclovir |
chenodeoxycholate |
198% drug recovery |
[114] |
Prodrug |
steroidal pyrazoles |
glycodeoxycholic acid |
Higher uptake with monoanionic form |
[115] |
Prodrug |
gabapentin |
chenodeoxycholic acid |
Higher uptake with single charge |
[117] |
Prodrug |
Asp-β-benzyl ester |
cholic acid |
Inhibition of taurocholate uptake |
[119] |
Prodrug |
cytarabine |
ursodeoxycholic acid |
Relative bioavailability 209% |
[120] |
Prodrug |
camptothecin |
deoxycholic acid |
65.48% uptake inhibition by taurocholate in cell spheroids |
[121] |
Prodrug |
LWMH |
deoxycholic acid |
ASBT-colocalization |
[92] |
Electrostatic |
trospium chloride |
Glycochenodeoxycholate, taurodeoxycholate |
Enhanced permeation in Caco-2 |
[123] |
Electrostatic |
ceftriaxone |
cholyethyendiaine |
Relative bioavailability 1300% |
[124] |
Electrostatic |
LWMH |
deoxycholylethylamine |
Relative bioavailability 2500% |
[125] |
Electrostatic |
EGFR2R-lytic hybrid peptide |
taurodeoxycholate |
64% tumor volume |
[126] |
Prodrug/Electrostatic |
LHT7 |
tetrameric deoxycholic acid/deoxycholylethylamine |
Relative bioavailability 916% |
[127] |
Electrostatic |
ibandronate |
Nα-deoxycholyl-L-lysyl-methylester |
Relative bioavailability 430% |
[164] |
Liposomes |
salmon calcitonin |
taurodeoxycholate |
Relative bioavailability 710% |
[165] |
Liposomes |
insulin |
deoxycholic acid |
Relative bioavailability 143% |
[142] |
Liposomes |
Exendin-4 |
glycocholic acid |
Bioavailability 19.5% to s.c. injection |
[143] |
Bilosomes |
haemagglutinin antigen |
deoxycholic acid |
Higher sIgA titer |
[146] |
Bilosomes |
hepatitis B surface antigen |
sodium deoxycholate |
Higher sIgA titer |
[147] |
Bilosomes |
diphtheria toxoid |
sodium deoxycholate |
Higher sIgA titer |
[148] |
Bilosomes |
fenofibrate |
sodium deoxycholate |
Relative bioavailability 513% |
[149] |
SaNPs |
felodipine |
sodium taurocholate |
Relative bioavailability 160% |
[151] |
SaNPs |
vitamin K |
glycocholic acid |
Higher drug stability/solubility |
[155] |
SaNPs |
heparin-docetaxel |
taurocholic acid |
Relative bioavailability 132% |
[152] |
SaNPs |
quantum Dots |
deoxycholic acid |
Jejunum/ileum accumulation |
[153] |
SaNPs |
silybin |
sodium cholate |
Relative bioavailability 252% |
[156] |
Nanoparticles |
rhodamine B |
deoxycholic acid |
Relative bioavailability 181% |
[158] |